<DOC>
	<DOCNO>NCT02702973</DOCNO>
	<brief_summary>The high dos interferon α-2b therapy patient melanomas skin may induce retinopathy , especially patient hypertension diabetes , patient follow treatment .</brief_summary>
	<brief_title>Characteristic Analysis Retinopathy Associated With High Doses Interferon α-2b Therapy</brief_title>
	<detailed_description>Patients melanomas skin whose tumor resect completely collect . The detailed ocular examination include intraocular pressure , slit lamp microscope , indirect ophthalmoscope color fundus photography do induction therapy , 2 week induction therapy , whole course induction therapy month maintenance treatment period . Fundus examination carry experienced ocular fundus doctor retinopathy characteristic record .</detailed_description>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<criteria>1 . Men woman , least 18 year age . 2 . ECOG performance status 0 1 . 3 . Patients must histologically confirm stage IB stage III primary melanoma cutaneous origin ( AJCC 7th edition classification ) . 4 . Must complete primary therapy ( wide excision without lymphadenectomy ) . 1 . Mucous membrane ocular melanoma . 2 . Any evidence distant metastasis ( CTscan brain , Chest X ray CT , abdominal ultrasound CT ultrasound regional lymph node screen ) . 3 . Patients retinopathy baseline fundoscopic examination start interferon therapy . 4 . History malignancy within last ten year ( except basal cell carcinoma squamous cell carcinoma skin carcinoma situ cervix ) . 5 . Patients severe cardiac disease ( e.g . NYHA Functional Class III IV , myocardial infarction within 6 month , ventricular tachyarrhythmias require ongoing treatment , unstable angina ) , severe liver disease severe renal disease . 6 . Patients history depression psychiatric diseases require hospitalisation . 7 . History presence autoimmune disease ( i.e . autoimmune hepatitis , thyroid autoimmune dysfunction , systemic lupus erythematodes ) , 8 . Unwilling unable comply requirement protocol duration study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Characteristic analysis</keyword>
</DOC>